UK Court Strikes Down Infosint Patent In Citalopram Suit

Law360, New York (April 14, 2011, 7:46 PM EDT) -- A London court on Thursday invalidated an Infosint SA patent covering an intermediate compound used in Danish drugmaker H. Lundbeck A/S' antidepressant Citalopram, handing Lundbeck a victory in its bid to revoke the patent.

Justice Christopher Floyd of the High Court of Justice, Chancery Division, ruled that claims 1 and 22 of the disputed Infosint patent — European Patent (UK) 1 118 614 — are invalid for obviousness over two papers authored by a Mobil Chemical Co. scientist, despite rejecting Lundbeck's bid to invalidate the patent...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.